Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

InMed Pharmaceuticals (INM) Other Gross PP&E Adjustments (2021 - 2025)

Historic Other Gross PP&E Adjustments for InMed Pharmaceuticals (INM) over the last 5 years, with Q2 2025 value amounting to $2.3 million.

  • InMed Pharmaceuticals' Other Gross PP&E Adjustments fell 1054.58% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year decrease of 1054.58%. This contributed to the annual value of $2.3 million for FY2025, which is 1054.58% down from last year.
  • According to the latest figures from Q2 2025, InMed Pharmaceuticals' Other Gross PP&E Adjustments is $2.3 million, which was down 1054.58% from $2.3 million recorded in Q1 2025.
  • InMed Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $2.6 million for Q4 2023, and its period low was $549195.0 during Q3 2021.
  • In the last 5 years, InMed Pharmaceuticals' Other Gross PP&E Adjustments had a median value of $1.6 million in 2023 and averaged $1.9 million.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 15869.17% in 2022, and later tumbled by 1094.73% in 2025.
  • Quarter analysis of 5 years shows InMed Pharmaceuticals' Other Gross PP&E Adjustments stood at $1.4 million in 2021, then grew by 0.25% to $1.4 million in 2022, then soared by 83.38% to $2.6 million in 2023, then dropped by 8.99% to $2.4 million in 2024, then decreased by 1.71% to $2.3 million in 2025.
  • Its Other Gross PP&E Adjustments was $2.3 million in Q2 2025, compared to $2.3 million in Q1 2025 and $2.4 million in Q4 2024.